| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/23/2004 | WO2004018657A1 Model epithelial cell cultures |
| 02/23/2004 | CA2447824A1 Model epithelial cell cultures |
| 02/19/2004 | WO2004015395A2 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | WO2004015394A2 Cancer diagnostics and prognostics |
| 02/19/2004 | WO2004015389A2 Methods of identifying compouds that modulate igg mediated mast cell activation |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004015115A1 Plastid transformation using modular vectors |
| 02/19/2004 | WO2004015113A2 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
| 02/19/2004 | WO2004015102A1 Olfactory ensheathing cells (oecs) in an extracellular matrix for use in axon regeneration |
| 02/19/2004 | WO2004015095A1 MODIFIED CYTOCHROME c OXIDASE AND MITOCHONDRIA |
| 02/19/2004 | WO2004015092A1 Method for producing stem cells using morulae or blastocysts |
| 02/19/2004 | WO2004015091A2 Preparation of type ii pneumocytes from stem cells |
| 02/19/2004 | WO2004015090A2 Innervated artificial tissues and uses thereof |
| 02/19/2004 | WO2004015081A2 Methods for treating circadian rhythm phase disturbances |
| 02/19/2004 | WO2004015077A2 Compositions and methods for neural differentiation of embryonic stem cells |
| 02/19/2004 | WO2004015073A2 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015072A2 Mrbs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | WO2004015071A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015070A2 Isolation and identification of t cells |
| 02/19/2004 | WO2004015067A2 Sperm-specific cation channel, catsper-3, and uses therefor |
| 02/19/2004 | WO2004015066A2 Sperm-specific cation channel, catsper-4, and uses therefor |
| 02/19/2004 | WO2004015065A2 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 02/19/2004 | WO2004015057A2 Mucin-immunoglobulin fusion proteins |
| 02/19/2004 | WO2004015056A2 Immunomodulating compositions, processes for their production and uses therefor |
| 02/19/2004 | WO2004014955A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 02/19/2004 | WO2004014952A2 Specific probnp(1-108) antibodies for diagnosing heart failure |
| 02/19/2004 | WO2004014939A2 Expansion of cells using thrombopoietin and anti-transforming growth factor-beta |
| 02/19/2004 | WO2004014420A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | WO2004014314A2 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
| 02/19/2004 | WO2004014302A2 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | WO2004014301A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004014212A2 Self-assembled muscle-powered microdevices |
| 02/19/2004 | WO2004007726A3 Brachyspira hyodysenteriae vaccine |
| 02/19/2004 | WO2004001024A3 Genetically engineered keratinocytes expressing at least one growth factor and/or activated egf receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes |
| 02/19/2004 | WO2003106661A3 Glutamine-free medium |
| 02/19/2004 | WO2003102584A3 Semaphorin-like proteins and methods of using same |
| 02/19/2004 | WO2003100060A3 Muc-1 antigen with reduced number of vntr repeat units |
| 02/19/2004 | WO2003095605A3 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/19/2004 | WO2003087318A3 Truncated 24 kda basic fibroblast growth factor |
| 02/19/2004 | WO2003085092B1 Cellular transplantation for heart regeneration |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003075790A3 Gas-plasma treatment of implants |
| 02/19/2004 | WO2003064637A9 Method and system for myocardial infarction repair |
| 02/19/2004 | WO2003054172A3 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 02/19/2004 | WO2003052051A3 Adeno-associated virus (aav) serotype 8 sequences |
| 02/19/2004 | WO2003050275A3 Method of isolation and purification of trypsin from pronase and use thereof |
| 02/19/2004 | WO2003050265A3 Compositions and methods for normalizing assays |
| 02/19/2004 | WO2003048193A3 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 02/19/2004 | WO2003042364A3 Identifying and controlling the growth of estrogen-responsive cells |
| 02/19/2004 | WO2003040341A3 Anti-hepatitis a virus antibodies |
| 02/19/2004 | WO2003036261A3 Drug development by rapid neuroimaging of neural cells |
| 02/19/2004 | WO2003035104B1 Compositions and methods for selected tumor treatment |
| 02/19/2004 | WO2003012049A3 Methods and composition concerning herpes virus us3 and bad-involved apoptosis |
| 02/19/2004 | WO2003010294A3 Genes involved in the biosynthesis of isopentenyl diphosphate in hevea brasiliensis latex |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2002091991A3 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 02/19/2004 | WO2002090514A8 Epidermal growth factor receptorantisense oligonucleotides |
| 02/19/2004 | WO2002083867A3 Ires enabled gene trapping in plants |
| 02/19/2004 | WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 02/19/2004 | WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 02/19/2004 | WO2002077206A9 Compositiona and methods useful for hcv infection |
| 02/19/2004 | WO2002070023A3 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 02/19/2004 | WO2002068386A3 Tools and methods for identifying ppar$g(d)-specific agonists and antagonists |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002059248A3 A novel gene associated with regulation of adiposity and insulin response |
| 02/19/2004 | WO2002052039A3 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 02/19/2004 | US20040034882 Transgenic rodent with mutation in one allele of the corticotropin releasing factor receptor 2 protein for use as animal model in treating and diagnosing anxiety, depression, obesity and diabetes |
| 02/19/2004 | US20040034880 Comprises trangenic caenorhabditis elegans mutants associated with constitutive pharyngeal pumping, increased gut permeability and/or altered molecular transport for use as animal model and drug screening tools |
| 02/19/2004 | US20040034878 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 02/19/2004 | US20040034197 Biosynthesizing trypsin and/or trypsinogen amino acid sequences, analogs and catalytic polypeptides with altered active sites and binding domains which recognize and bind to ester leaving groups |
| 02/19/2004 | US20040034195 Multimerized highly functional antifreeze protein |
| 02/19/2004 | US20040034194 Comprises thera.peutic polypeptide for treating and preventing cancer, obesity, diabetes, hyper/hypotension, eating, nervous system and sexual disorders |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033977 Oligonucleotide modulation of cell adhesion |
| 02/19/2004 | US20040033975 Whole cell engineering using real-time metabolic flux analysis |
| 02/19/2004 | US20040033971 Polypeptides and nucleic acids encoding same |
| 02/19/2004 | US20040033956 Method of promoting production of living tissue equivalents |
| 02/19/2004 | US20040033605 Using recombinant adenoviral vectors for the delivery and expression of heterologous nucleic acids in nervous system tissues; gene therapy |
| 02/19/2004 | US20040033599 Medium for preparing dedifferentiated cells |
| 02/19/2004 | US20040033598 Compositions and methods for generating skin |
| 02/19/2004 | US20040033597 Multipotent neural stemcells from peripheral tissues and uses thereof |
| 02/19/2004 | US20040033596 Inducing site-specific mitotic recombination in the plurality of isolated parent cells from heterozygous cellular library, culturing these cells to produce daughter cells, selecting daughter cells containing homogygous genetic modification |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033594 Comprises RNA viral sequences for use in development of diagnostics and genetic vaccines against viral infection |
| 02/19/2004 | US20040033577 Herbicides test method |
| 02/19/2004 | US20040033566 Genetically engineered serine protease for diagnosis and treatment of blood disorders |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033564 Method for increasing solubility of target protein using RNA-binding protein as fusion partner |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033542 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 02/19/2004 | US20040033527 Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain |
| 02/19/2004 | US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |